Association of angiotensin-converting enzyme I/D and α-actinin-3 R577X genotypes with metabolic syndrome risk factors in Korean children

Bruce, 2010, The developmental origins mechanisms, and implications of metabolic syndrome, J Nutr, 140, 648, 10.3945/jn.109.111179 Benzinou, 2008, Common nonsynonymous variants in PCSK1 confer risk of obesity, Nat Genet, 40, 943, 10.1038/ng.177 Berndt, 2013, Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture, Nat Genet, 45, 501, 10.1038/ng.2606 Frayling, 2007, A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity, Science, 316, 889, 10.1126/science.1141634 MacArthur, 2004, A gene for speed? The evolution and function of α-actinin-3, Bioessays, 26, 786, 10.1002/bies.20061 Zempo, 2010, ACTN3 polymorphism affects thigh muscle area, Int J Sports Med, 31, 138, 10.1055/s-0029-1242808 Ren, 2010, Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease, J Mol Med, 88, 993, 10.1007/s00109-010-0663-9 Bosello, 2000, Visceral obesity and metabolic syndrome, Obes Rev, 1, 47, 10.1046/j.1467-789x.2000.00008.x Abraham, 2002, Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure, Circulation, 106, 1794, 10.1161/01.CIR.0000031735.86021.79 Lee, 2002, ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients, Diabetes Care, 25, 1002, 10.2337/diacare.25.6.1002 Licata, 2003, Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects, Metabolism, 52, 999, 10.1016/S0026-0495(03)00150-1 Strazzullo, 2003, Genetic variation in the renin–angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study, Ann Intern Med, 138, 17, 10.7326/0003-4819-138-1-200301070-00007 Matthews, 1985, Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Zimmet, 2007, The metabolic syndrome in children and adolescents – an IDF consensus report, Pediatr Diabetes, 8, 299, 10.1111/j.1399-5448.2007.00271.x Korea Centers For Disease Control and Prevention, 2007 Gómez-Gallego, 2009, Endurance performance: genes or gene combinations?, Int J Sports Med, 30, 66, 10.1055/s-2008-1038677 Rigat, 1990, An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels, J Clin Invest, 86, 1343, 10.1172/JCI114844 Eisenmann, 2009, ACE I/D genotype, adiposity, and blood pressure in children, Cardiovasc Diabetol, 8, 14, 10.1186/1475-2840-8-14 Rankinen, 2006, The human obesity gene map: the 2005 update, Obesity, 14, 529, 10.1038/oby.2006.71 Dominici, 2014, Modulation of the action of insulin by angiotensin-(1-7), Clin Sci, 126, 613, 10.1042/CS20130333 Cooper, 2006, Preventing diabetes in patients with hypertension: one more reason to block the renin–angiotensin system, J Hypertens Suppl, 24, S57, 10.1097/01.hjh.0000220408.91987.eb Mason, 2011, Bimodal distribution of RNA expression levels in human skeletal muscle tissue, BMC Genomics, 12, 98, 10.1186/1471-2164-12-98 Berman, 2010, A gene for speed: the emerging role of alpha-actinin-3 in muscle metabolism, Physiology (Bethesda), 25, 250, 10.1152/physiol.00008.2010 MacArthur, 2008, An Actn3 knockout mouse provides mechanistic insights into the association between α-actinin-3 deficiency and human athletic performance, Hum Mol Genet, 17, 1076, 10.1093/hmg/ddm380 Quinlan, 2010, Alpha-actinin-3 deficiency results in reduced glycogen phosphorylase activity and altered calcium handling in skeletal muscle, Hum Mol Genet, 19, 1335, 10.1093/hmg/ddq010 Grundy, 2005, Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 Kelley, 2002, Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes, Diabetes, 51, 2944, 10.2337/diabetes.51.10.2944 Kim, 2000, Lipid oxidation is reduced in obese human skeletal muscle, Am J Physiol Endocrinol Metab, 279, E1039, 10.1152/ajpendo.2000.279.5.E1039 Simoneau, 1995, Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women, FASEB J, 9, 273, 10.1096/fasebj.9.2.7781930 Xi, 2012, The ACE insertion/deletion polymorphism and its association with metabolic syndrome, Metabolism, 61, 891, 10.1016/j.metabol.2011.10.022